← All organizations

Allergy Therapeutics

For profitWebsite ↗

Also known as: Allergy Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2022

Timeline

1930s

Jan 1, 1934
Allergy Therapeutics— Founded

2010s

Jun 5, 2015
Alerpharma— Acquired

Drugs by trial phase (7 distinct, 23 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tree mata mpl

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Alerpharma

Recent trials (34)

NCT05476497Lead sponsorPhase 1Oct 31, 2022
NCT05476497Study directorPhase 1Oct 31, 2022
NCT05540717Lead sponsorPhase 3Oct 11, 2022
NCT04687059Lead sponsorPhase 2/Phase 3Oct 19, 2020
NCT03931993Study directorPhase 1Jan 16, 2017
NCT03931993Lead sponsorPhase 1Jan 16, 2017
NCT02582073Lead sponsorPhase 2Nov 7, 2015
NCT02582073Study directorPhase 2Nov 7, 2015
NCT02557633Study directorPhase 1Aug 1, 2015
NCT02557633Lead sponsorPhase 1Aug 1, 2015
NCT00423787Lead sponsorPhase 3Mar 1, 2007
NCT00423787Study chairPhase 3Mar 1, 2007
NCT00414141Lead sponsorPhase 3Nov 1, 2006
NCT00414141Study chairPhase 3Nov 1, 2006
NCT00387478Lead sponsorPhase 2Oct 1, 2006

Details

Founded: Worthing, GB Jan 1, 1934
Last known activity: Oct 31, 2022